Table G-11Characteristics of placebo-controlled trials of benzodiazepines omitted from main analyses because of high risk of bias

TrialArm
Dose mg/Day (N)		Duration (Weeks)Population Trauma TypeBaseline PTSD SeverityaMean
Age (Y)		% Female
% Nonwhite
Braun et al., 1990169Alprazolam (1.5 to 6) (7)
Placebo (9)		12Male and female
Mixed		PTSD-Scale
30.0 to 30.9		38NR

NR
a

When mean data for baseline PTSD severity were not reported for the total sample but were presented for each study arm, we provide the range across arms.

mg = milligram; N = number; NR = not reported; PTSD = posttraumatic stress disorder; PTSD-Scale = Posttraumatic Stress Disorder Scale; y = year.

From: Appendix G, Documentation of Trials Rated High Risk of Bias

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 207.
Forman-Hoffman V, Middleton JC, Feltner C, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.